←
Precede Biosciences37 posts
Precede Biosciences avatar

Precede Biosciences

@Precede_Bio

Precede Bio is impacting precision medicine with a first-in-class liquid biopsy platform, redefining what can be learned from a simple🩸blood draw.

◷ Joined July 2023▧ 33 Photos and videos
Precede Biosciences avatar
Precede Biosciences@Precede_Bio·Jan 12

We’re proud to share that Precede Biosciences has secured $83.5M in total financing to scale our next-generation precision diagnostics platform. This capital supports continued growth amid strong commercial traction with leading biopharmaceutical developers advancing the next wave of precision medicines. More broadly, this milestone reflects growing conviction in the need for diagnostics built for target expression and pathway biology, the biomarkers most relevant to next-generation precision medicines, including antibody drug conjugates (ADCs), targeted protein degraders, and other next-generation precision medicines. We’re grateful for the continued support of our existing investors, including Illumina Ventures, 5AM Ventures, Bristol Myers Squibb, Osage University Partners (OUP), Binney Street Capital, and Lilly Asia Ventures, and excited to welcome new strategic and institutional partners, including Labcorp Venture Fund, UPMC Enterprises, Mirae Asset Capital Life Science, Mirae Asset Capital, 28 Capital LLC, and Alexandria Venture Investments. We’re also grateful for the commitment and belief of the team at SVB, who support the Precede Bio mission through strategic, non-dilutive financing. Together, this group adds deep expertise to the Precede mission, a mission to meaningfully impact drug development success rates and ensure patients receive treatments fully aligned to the biology of their disease. View press release: precede.bio/news/seriesb-fin…

Post attachment
Precede Biosciences avatar
Precede Biosciences@Precede_Bio·17 Jun 2024

@Precede_Bio is pleased to announce the newest member of our Scientific Advisory Board, Doron Lipson. Dr. Lipson is truly a visionary leader and we are grateful to benefit from his many decades of leadership in genomic application development to advance our comprehensive epigenomic liquid biopsy platform. #ScientificAdvisoryBoard

Post attachment
Precede Biosciences avatar
Precede Biosciences@Precede_Bio·8 Jun 2024

Today is Boston's Pride celebration, a day in which our hometown celebrates the rich diversity and culture of the LGBTQ+ community. At @Precede_Bio, we strive to build a diverse and inclusive workplace that honors and values each of our team members. This Pride month, we celebrate and give a shout out to our LGBTQ+ team members, collaborators, friends, and family members.

Post attachment
Precede Biosciences avatar
Precede Biosciences@Precede_Bio·8 Apr 2024

It was a busy day for @Precede_Bio at our #AACR24 poster today. Great engagement and discussion. If you haven’t seen what we are up to, we have two more to go…come visit the team - @corrie_painter, Jonathan Beagan, Jamey Guess - on April 9 to see our data in GEA cancer and April 10 for our data in Lung cancer.

Post attachment